IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP)

A. Demchuk (Vinnytsia, Ukraine)

Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Session: Does economisation of medicine transfer into benefits for patients?
Session type: Thematic Poster
Number: 2796
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Demchuk (Vinnytsia, Ukraine). IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP). 2796

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019

THE NEW OPPORTUNITIES OF THE PERSONALISED PULMONARY REHABILITATION PROGRAMS IN MANAGEMENT OF COPD PATIENTS: TARGETS AND GOALS
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018

A STUDY OF CLINICORADIOLOGICAL AND MICROBIOLOGICAL PROFILE AND BIOMARKERS IN  CASES OF COMMUNITY ACQUIRED PNEUMONIA ADMITTED IN A TERTIARY CARE HOSPITAL
Source: Virtual Congress 2021 – Pneumonia
Year: 2021

ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


CARDIOVASCULAR RISK (CVR) AND EFFECTS ON THE QUALITY OF LIFE AFTER A PHYSICAL REHABILITATION PROGRAM ON COPD PATIENTS BASED ON THEIR PHENOTYPE: EXACERBATOR (E) OR NON-EXACERBATOR (NE)
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


CHARACTERIZATION AND SURVIVAL OF PATIENTS WITH SPINAL MUSCLE ATROPHY TYPE 1 ON HOME MECHANICAL VENTILATION PROGRAM OF MINISTRY OF HEALTH, CHILE
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017


HEALTH RELATED QUALITY OF LIFE (HRQoL) AMONG PATIENTS WITH NON CYSTIC FIBROSIS BROCHIECTASIS (BE) IN STABLE PHASE
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018

IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON PULMONARY FUNCTION IN MIDDLE-AGE AND OLDER PATIENTS WITH TYPE 2 DIABETES
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

PREDICTING THE MORTALITY OF PNEUMONIA PATIENTS VISITING THE EMERGENCY DEMARTMENT THROUGH MACHINE LEARNING
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


THE IMPACT OF PULMONARY REHABILITATION ON PHYSICAL ACTIVITY AND PHYSICAL FITNESS LEVELS IN LUNG TRANSPLANT CANDIDATES; PRELIMINARY STUDY RESULTS
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


WHAT TOOLS AND RESOURCES DO PULMONARY REHABILITATION TEAMS USE TO DELIVER EDUCATION?
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020


FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY.
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


EFFICACY OF A BUNDLE FOR PREVENTION OF VENTILATOR ASSOCIATED PNEUMONIA IN AN ADULT INTENSIVE CARE UNIT
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


THE ASSOCIATION ANALYSIS OF CHEMILUMINESCENCE OF NEUTROPHILS OF THE BLOOD WITH PATHOGENETIC FACTORS OF COPD
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE.
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


THE CENTER FOR DISTANCE LEARNING AND MONITORING IN EDUCATION OF TB SPECIALISTS AND MEDICAL STUDENTS.
Source: International Congress 2019 – Medical education
Year: 2019

Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017